BrainStorm Announces Presentations at June 2022 Scientific Conferences

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announces...

Related Keywords

Stanford School ,California ,United States ,National Harbor ,Maryland ,United Kingdom ,Edinburgh ,City Of ,San Francisco ,Scotland ,John Mullaly ,Chaim Lebovits ,Brainstorm Cell Therapeutics Inc ,California Institute For Regenerative Medicine ,Lifesci Advisors ,Stanford School Of Medicine ,California Pacific Medical Center ,Drug Administration ,Nasdaq ,European Network To Cure ,Consortium Of Multiple Sclerosis Centers ,National Ms Society ,European Medicines Agency ,Brainstorm Cell Therapeutics ,European Network ,Multiple Sclerosis Centers ,Edinburgh Scotland ,Town Trial ,Jonathan Katz ,Thurs June ,Binocular Low Contrast Letter Acuity ,Ralph Kern ,Chief Medical Officer ,Brainstorm Cell ,Thursday June ,Christopher Lock ,Cells Maintain Neurotrophic ,Immunomodulatory Effects ,Modulator Siponimod ,Sidney Spector ,Senior Vice President ,Medical Affairs ,Global Strategy ,Cell Therapeutics ,Storm Cell Therapeutics ,Orphan Drug ,California Institute ,Regenerative Medicine ,Harbor Statement ,Sci Advisors ,